10.1038/mtm.2016.20 7 AndreaniM.MannaM.LucarelliG.TonucciP.AgostinelliF.RipaltiM.et al
Decide now what circumstances will trigger medication resumption
Benefits reported by MEDVi patients include: Losing an average of 15-20% of total body weight Experiencing fewer cravings and stronger appetite control Improved mood, energy levels, and sleep quality High patient satisfaction, with 9 out of 10 calling it the most effective treatment they have tried Long-term success, with 93% maintaining their results after six months GLP-1 therapy is more than a weight loss tool
GLP-1 Receptor Agonists: These medications stimulate GLP-1 receptors, leading to several beneficial effects: Increased Insulin Release: They prompt the pancreas to release more insulin when blood sugar levels are high, helping to lower glucose
This often leads to fatigue and dizziness among patients, making it challenging to stay active and continue treatment
Report any suspected side effects via the MHRA Yellow Card Scheme